LACTASE PERSISTENCE
|
phenotype |
|
Disease or Syndrome
|
15
|
9
|
0.140 |
None |
1.000 |
4 |
8
|
2008 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.030 |
None |
1.000 |
3 |
|
2006 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
2 |
1
|
2015 |
2018 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.110 |
None |
1.000 |
2 |
2
|
2017 |
2018 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
2 |
1
|
2018 |
2018 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
360
|
194
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Adult Anaplastic Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
29
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Anaplastic Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
66
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hip circumference
|
phenotype |
|
Clinical Attribute
|
68
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Well Differentiated Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
270
|
22
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mantle cell lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
466
|
19
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Neck Pain Score 1
|
phenotype |
|
Finding
|
5
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Childhood Anaplastic Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
29
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mild Adverse Event
|
phenotype |
|
Finding
|
5
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
response to simvastatin
|
phenotype |
|
Cell Function
|
21
|
37
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
ECOG Performance Status 1
|
phenotype |
|
Finding
|
5
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Luminal B Breast Carcinoma
|
disease |
|
Neoplastic Process
|
103
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.010 |
None |
< 0.001 |
1 |
1
|
2010 |
2010 |
oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
282
|
21
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3926
|
712
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2084
|
288
|
0.010 |
None |
< 0.001 |
1 |
1
|
2010 |
2010 |
Hepatitis C
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1768
|
347
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |